Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

. Correction for Yang et al., Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression. Proc Natl Acad Sci U S A 2026;123:e2626420123.
PMID: 42607226


Privacy Policy